EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Persistent Developmental Stuttering
Interventions
DRUG

Pagoclone

DRUG

Placebo

Trial Locations (16)

10021

Social Psychiatry Research Institute, New York

11235

Social Psychiatry Research Institute, Brooklyn

15213

University of Pittsburgh Medical Center, Pittsburgh

30328

Atlanta Institute of Medicine & Research-Atlanta Clinic, Atlanta

45408

Midwest Clinical Research Center, Dayton

46202

Davis Clinic PC, Indianapolis

48073

Pivotal Research Centers, Royal Oak

66211

Vince and Associates Clinical Research, Overland Park

78229

University of Texas, Health Science Center, San Antonio

78756

FutureSearch Trials, Austin

84132

University of Utah, Salt Lake City

85381

Pivotal Research Centers, Peoria

91786

Pacific Clinical Research Medical Group, Upland

92506

Pharmacology Research Institute, Riverside

92868

University of California, Irvine Medical School, Orange

33613-4788

University of South Florida College of Medicine, Tampa

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY